Kyntra Bio (KYNB) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $121000.0.
- Kyntra Bio's Receivables - Net fell 9958.32% to $121000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $121000.0, marking a year-over-year decrease of 9958.32%. This contributed to the annual value of $481000.0 for FY2024, which is 9060.73% down from last year.
- According to the latest figures from Q3 2025, Kyntra Bio's Receivables - Net is $121000.0, which was down 9958.32% from $136000.0 recorded in Q2 2025.
- Kyntra Bio's Receivables - Net's 5-year high stood at $43.9 million during Q1 2022, with a 5-year trough of $121000.0 in Q3 2025.
- For the 5-year period, Kyntra Bio's Receivables - Net averaged around $20.0 million, with its median value being $17.7 million (2023).
- Its Receivables - Net has fluctuated over the past 5 years, first skyrocketed by 11005.44% in 2024, then crashed by 9960.36% in 2025.
- Quarter analysis of 5 years shows Kyntra Bio's Receivables - Net stood at $17.4 million in 2021, then fell by 6.33% to $16.3 million in 2022, then plummeted by 68.58% to $5.1 million in 2023, then plummeted by 90.61% to $481000.0 in 2024, then plummeted by 74.84% to $121000.0 in 2025.
- Its Receivables - Net stands at $121000.0 for Q3 2025, versus $136000.0 for Q2 2025 and $147000.0 for Q1 2025.